METHODS	Sixty-two patients ( 33 males and 29 females ) aged > or = 18 with chronic hepatitis C not treated previously were tested for HCV genotype and randomly assigned to receive interferon ( IFN ) alfa 2b 3 million units 3 times per week alone or in combination with ribavirin 1000-1200 mg orally per day for 48 weeks .\